التفاصيل البيبلوغرافية
العنوان:
Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan
المؤلفون:
Kazimieras Maneikis , Ugne Ringeleviciute , Justinas Bacevicius , Egle Dieninyte-Misiune , Emilija Burokaite , Gintare Kazbaraite , Marta Monika Janusaite , Austeja Dapkeviciute , Andrius Zucenka , Valdas Peceliunas , Lina Kryzauskaite , Vytautas Kasiulevicius , Donata Ringaitiene , Birute Zablockiene , Tadas Zvirblis , Germanas Marinskis , Ligita Jancoriene , Laimonas Griskevicius
المصدر:
International Journal of Cardiology: Heart & Vasculature, Vol 32, Iss , Pp 100685- (2021)
بيانات النشر:
Elsevier, 2021.
سنة النشر:
2021
المجموعة:
LCC:Diseases of the circulatory (Cardiovascular) system
مصطلحات موضوعية:
QT interval , COVID-19 , Hydroxychloroquine , Azithromycin , Diseases of the circulatory (Cardiovascular) system , RC666-701
الوصف:
Aims: To assess cardiac safety in COVID-19 patients treated with the combination of Hydroxychloroquine and Azithromycin using arrhythmia risk management plan. Methods and results: We retrospectively examined arrhythmia safety of treatment with Hydroxychloroquine and Azithromycin in the setting of pre-defined arrhythmia risk management plan. The data was analyzed using R statistical package version 4.0.0. A two-tailed p-value
نوع الوثيقة:
article
وصف الملف:
electronic resource
اللغة:
English
تدمد:
2352-9067
Relation:
http://www.sciencedirect.com/science/article/pii/S2352906720303833 ; https://doaj.org/toc/2352-9067
DOI:
10.1016/j.ijcha.2020.100685
URL الوصول:
https://doaj.org/article/430bd6999e164233982152c0821c6c5b
رقم الأكسشن:
edsdoj.430bd6999e164233982152c0821c6c5b
قاعدة البيانات:
Directory of Open Access Journals
Full Text via ClinicalKey 
Full Text Finder